RNXT Earnings Date: Nov 5, 2026 (Estimated) — RenovoRx, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is RNXT's next earnings date?
RenovoRx, Inc. (RNXT) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.05 on revenue of $1.1M.
How did RNXT do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), RenovoRx, Inc. posted EPS of -$0.05 versus the -$0.07 estimate, a beat of 37.5%. Revenue was $909,000 against a $703,750 estimate. The stock's 1-day post-earnings move was +12.5%.
How much does RNXT stock move after earnings?
RNXT beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 9.4% (up or down) in the day after earnings.
About RenovoRx, Inc.
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.07 | -0.05 | +37.50% | $909,000 | ✅ Beat | +12.50% | +17.41% | +57.14% |
| 2026-05-14 | Q1 2026 | -0.08 | -0.08 | +0.00% | $563,000 | ➖ Inline | -4.09% | +3.11% | +3.60% |
| 2026-03-30 | Q4 2025 | -0.08 | -0.08 | +0.00% | $238,000 | ➖ Inline | -5.61% | -15.89% | -22.33% |
| 2025-11-13 | Q3 2025 | -0.08 | -0.08 | +0.00% | $266,000 | ➖ Inline | -23.03% | -20.11% | -3.52% |
| 2025-08-14 | Q2 2025 | -0.08 | -0.08 | +0.00% | $422,000 | ➖ Inline | -22.94% | -27.95% | +2.42% |
| 2025-03-31 | Q4 2024 | -0.10 | -0.12 | -20.00% | $43,000 | ❌ Miss | -3.03% | -20.20% | -3.03% |
| 2024-11-13 | Q3 2024 | -0.12 | -0.10 | +16.67% | $0 | ✅ Beat | -0.47% | +1.35% | +20.53% |
| 2024-08-13 | Q2 2024 | -0.10 | -0.10 | +0.00% | $0 | ➖ Inline | -3.45% | -8.62% | -7.76% |
Showing last 8 quarters.